Molecular Imaging

Latest News

New Study Shows Impact of Tau-Positive PET in Risk Stratification for Dementia and Alzheimer’s Disease
New Study Shows Impact of Tau-Positive PET in Risk Stratification for Dementia and Alzheimer’s Disease

June 17th 2025

For people with mild cognitive impairment (MCI), new research suggests that a combination of amyloid-positive and tau-positive PET findings is linked to a nearly 70 percent risk of progressing to dementia in five years in comparison to an approximate 30 percent risk for those with amyloid β positive and tau-negative PET.

Meta-Analysis Shows Merits of (68Ga)Ga-FAPI-04 PET for Assessing GI Tumors and Metastases
Meta-Analysis Shows Merits of (68Ga)Ga-FAPI-04 PET for Assessing GI Tumors and Metastases

June 13th 2025

FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging

June 11th 2025

New PSMA PET Prep Product Now Available in the U.S.
New PSMA PET Prep Product Now Available in the U.S.

June 11th 2025

Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?

June 2nd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.